Srb Corp Abbott Laboratories Transaction History

Srb Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $86,302 - $101,582	-891 Reduced 20.43%	3,471 $351,000
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $48,100 - $56,429	506 Added 13.12%	4,362 $478,000
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $373,106 - $431,987	3,856 New	3,856 $374,000
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $1.08 Million - $1.31 Million	-10,626 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $340,929 - $417,448	-2,951 Reduced 21.74%	10,626 $1.5 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $125,876 - $139,255	-1,079 Reduced 7.36%	13,577 $1.6 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $1.55 Million - $1.83 Million	14,656 New	14,656 $1.7 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Srb Corp, based on Form 13F filings with the SEC.

Stay updated on Srb Corp with notifications on news.